Streptozocin Other names: Streptozotocin

Chemical formula: C₈H₁₅N₃O₇  Molecular mass: 265.221 g/mol  PubChem compound: 29327

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
L01AD04 Streptozocin L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AD Nitrosoureas
Discover more medicines within L01AD04

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
ZANOSAR Powder for concentrate for solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 18883-66-4
DrugBank Drug: DB00428
KEGG Drug: D05932
PubChem Compound: 29327
RxNorm Ingredient: 10114
SNOMED-CT Concept: 16915004
Streptozocin (substance)
UNII Identifier: 5W494URQ81
STREPTOZOCIN

Medicines

Streptozocin is an active ingredient of these brands:

United States (US)

Estonia (EE)

Finland (FI)

Japan (JP)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.